Background The International Academy of Cytology (IAC) Yokohama reporting system was recently proposed to serve as a standardized diagnostic platform for the cytological interpretation of breast fine needle aspiration biopsy (FNAB). Five cytological categories were suggested, linked to a certain risk of malignancy (ROM). The aim of this study was to assess the potency of this newly proposed reporting guideline, with a review of literatures. Methods This is a retrospective study over 8‐year duration in which all the breast FNABs performed in our institution were recategorized in accordance to the IAC Yokohama reporting system. Kappa coefficient was used to evaluate the agreement between the proposed cytological category and corresponding histological diagnosis, with the level of significance set at 5%. Cyto‐histopathological correlation and its diagnostic performance were also assessed. Results A total of 1136 breast FNABs were analyzed, including 31 repeat FNABs. Of these, 521 (47.1%) cases had matched histopathological results. Respective ROM for each category was: “insufficient” 13.6%, “benign” 0.4%, “atypical” 25.0%, “suspicious” 85.7%, and “malignant” 100%. There was substantial agreement (κ=0.757) between cytology and histopathological results. Our data revealed a high‐diagnostic specificity, sensitivity, positive and negative predictive value of 99.3% (95% CI: 97.6%‐99.9%), 94.2% (95% CI: 87.9%‐97.9%), 98.0% (95% CI: 92.5%‐99.5%), 98.0% (95% CI: 96.1%‐99.1%) respectively when both the “suspicious” and “malignant” cases were considered as positive tests, with area under the curve of 0.993. Conclusions The IAC Yokohama system is a reliable, evidence‐based, and standardized reporting system that helps to facilitate communication among cytopathologists, radiologists, and surgeons toward individualized patient management.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.